Search Results for "precision tool" | Oncology Voice Network

Michael Pietrack

The Four Employment Agreement Questions Every Pharma Executive Must Ask

Dec 18^th • 6 mins read

Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Sep 9^th • 5 mins read

Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

May 17^th • 2 mins read

Tom Caravela

How to Prepare for a Virtual or Video Interview

Mar 19^th • 1 min read

Tom Caravela

Resume Writing and Editing Tips for Pharma Professionals

Aug 8^th • 1 min read

Tom Caravela

MSL Evolution: New Trends and Titles That May Emerge

Apr 5^th • 1 min read

iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%

Sep 3^rd • 1 min read

iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

May 16^th • 5 mins read

Charles Oo, Barbara Ameer

Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic

Apr 29^th • 2 mins read

B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Apr 20^th • 8 mins read

A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Apr 20^th • 7 mins read

Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Dec 1^st • 4 mins read

J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Sep 26^th • 17 mins read

Shani Paluch-Shimon, Nathan I. Cherny, Elisabeth G.E. de Vries, Urania Dafni, Martine J. Piccart, Nicola Jane Latino, Fatima Cardoso

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

Sep 6^th • 20 mins read

Stefanie Broes, Robbe Saesen, Denis Lacombe, Isabelle Huys

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

Aug 16^th • 8 mins read

Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Jun 18^th • 30 mins read

Melissa H. Roberts & Gary T. Ferguson

Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions

Jun 18^th • 6 mins read

Muneera Al Hussain

Comment on: Oncology research in Saudi Arabia over a 10-year period. A synopsis

Jun 24^th • 3 mins read

Eric Q. Konnick

The regulatory landscape of precision oncology laboratory medicine in the United States - Perspective on the past 5 years and considerations for future regulation

May 22^nd • 8 mins read

Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

May 21^st • 8 mins read

Navigation

Results for 'precision tool'

The Four Employment Agreement Questions Every Pharma Executive Must Ask

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Job Search Checklist for Aspiring Medical Science Liaisons

How to Prepare for a Virtual or Video Interview

Resume Writing and Editing Tips for Pharma Professionals

MSL Evolution: New Trends and Titles That May Emerge

Clinical Educator Oncology Program Improves Adherence by 29%

Transforming oncology: Five frontiers driving progress in cancer care

Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions

Comment on: Oncology research in Saudi Arabia over a 10-year period. A synopsis

The regulatory landscape of precision oncology laboratory medicine in the United States - Perspective on the past 5 years and considerations for future regulation

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Related Topics

Navigation

Results for 'precision tool'

The Four Employment Agreement Questions Every Pharma Executive Must Ask

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Job Search Checklist for Aspiring Medical Science Liaisons

How to Prepare for a Virtual or Video Interview

Resume Writing and Editing Tips for Pharma Professionals

MSL Evolution: New Trends and Titles That May Emerge

Clinical Educator Oncology Program Improves Adherence by 29%​

Transforming oncology: Five frontiers driving progress in cancer care

Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions

Comment on: Oncology research in Saudi Arabia over a 10-year period. A synopsis

The regulatory landscape of precision oncology laboratory medicine in the United States - Perspective on the past 5 years and considerations for future regulation

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Related Topics

Clinical Educator Oncology Program Improves Adherence by 29%